Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints

Mikucki, M. E., Fisher, D. T., Matsuzaki, J., Skitzki, J. J., Gaulin, N. B., Muhitch, J. B., Ku, A. W., Frelinger, J. G. +4 more·2015·Nature Communications

DOI 10.1038/ncomms8458

Cited by (512)

Items 101–200 of 512

Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function
Lydia Dyck, Hannah Prendeville, Mathilde Raverdeau, Mieszko M. Wilk, Róisín M. Loftus, Aaron Douglas, Janet McCormack, Bruce Moran, Michael Wilkinson, Evanna L. Mills et al. · 2022 · The Journal of Experimental Medicine
CD4+ helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment
Xin Lei, Indu Khatri, Tom de Wit, Iris de Rink, Marja Nieuwland, Ron M Kerkhoven, Hans van Eenennaam, Chong Sun, Abhishek Dinkarnath Garg, Jannie G. Borst et al. · 2023 · Nature Communications
Epigenetic state determines the in vivo efficacy of STING agonist therapy
Falahat, Rana, Berglund, Anders, Perez-Villarroel, Patricio, Putney, Ryan M., Hamaidi, Imene, Kim, Sungjune, Pilon-Thomas, Shari, Barber, Glen N., Mulé, James J. · 2023 · Nature Communications
Cisplatin facilitates radiation-induced abscopal effects in conjunction with PD-1 checkpoint blockade through CXCR3/CXCL10-mediated T-cell recruitment
Luo, Ren, Firat, Elke, Gaedicke, Simone, Guffart, Elena, Watanabe, Tsubasa, Niedermann, Gabriele · 2019 · Clinical Cancer Research
Immunomodulatory Effects of Stereotactic Body Radiation Therapy: Preclinical Insights and Clinical Opportunities
Ariel E. E. Marciscano, Adriana Haimovitz‐Friedman, Percy P. Lee, Phuoc Tho Tran, Wolfgang A. Tomé, Chandan Guha, Feng‐Ming Kong, Arjun Sahgal, Issam El Naqa, Andreas Rimner et al. · 2019 · International Journal of Radiation Oncology*Biology*Physics
Senescent Tumor Cells Build a Cytokine Shield in Colorectal Cancer
Yong Won Choi, Young Hwa Kim, Seung Yeop Oh, Kwang Wook Suh, Young‐Sam Kim, Ga‐Yeon Lee, Jung Eun Yoon, Soon Sang Park, Young‐Kyoung Lee, Yoo Jung Park et al. · 2021 · Advanced Science
PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma
Sarah Cappuyns, Gino Philips, Vincent Vandecaveye, Bram Boeckx, Rogier Schepers, Thomas Van Brussel, Ingrid Arijs, Aurelie Mechels, Ayse Bassez, Francesca Lodi et al. · 2023 · Nature Communications
Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors
Emre Balta, Guido H. Wabnitz, Yvonne Samstag · 2021 · International Journal of Molecular Sciences
RNA Modification in the Immune System
Dali Han, Meng Michelle Xu · 2023 · Annual Review of Immunology
Intraoperative intravital microscopy permits the study of human tumour vessels
Daniel T. Fisher, Jason B. Muhitch, Minhyung Kim, Kurt C. Doyen, Paul N. Bogner, Sharon S. Evans, Joseph J. Skitzki · 2016 · Nature Communications
Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers
Nicolas Jacquelot, Connie P.M. Duong, Gabrielle Therese Belz, Laurence Zitvogel · 2018 · Frontiers in Immunology
L-Selectin Enhanced T Cells Improve the Efficacy of Cancer Immunotherapy
H. Angharad Watson, Ruban Rex Peter Durairaj, Julia Ohme, Markella Alatsatianos, Hanan Almutairi, Rebar N. Mohammed, Miriam Ann Vigar, Sophie G. Reed, Stephen J. Paisey, Christopher Marshall et al. · 2019 · Frontiers in Immunology
Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non–small cell lung cancer
Brett H. Herzog, John M. Baer, Nicholas C. Borcherding, Natalie L. Kingston, Jad I. Belle, Brett L. Knolhoff, Graham D. Hogg, Faiz F. Ahmad, Liang‐I Kang, Jessica Petrone et al. · 2023 · Science Translational Medicine
Cowpea mosaic virus stimulates antitumor immunity through recognition by multiple MYD88-dependent toll-like receptors
Chenkai Mao, Veronique Beiss, Jennifer L. Fields, Nicole F. Steinmetz, Steven Fiering · 2021 · Biomaterials
Tumor and Host Factors Controlling Antitumor Immunity and Efficacy of Cancer Immunotherapy
Stefani Spranger, Ayelet Sivan, Leticia P. Corrales, Thomas Frank Gajewski · 2016 · Advances in immunology
Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+ exhausted-like T cells
Siqi Li, Kun Li, Kang Wang, Haoyuan Yu, Xiang‐Yang Wang, Mengchen Shi, Zhixing Liang, Yang Zhou, Yongwei Hu, Yang Li et al. · 2023 · Nature Communications
Lymphocyte networks are dynamic cellular communities in the immunoregulatory landscape of lung adenocarcinoma
Giorgio Gaglia, Megan L. Burger, Cecily C. Ritch, Danae Rammos, Yang Dai, Grace E. Crossland, Sara Z. Tavana, Simon Warchol, Alex M. Jaeger, Santiago Naranjo et al. · 2023 · Cancer Cell
Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: an ATC-like and a PDTC-like
Riccardo Giannini, Sonia Moretti, Clara Ugolini, Elisabetta Macerola, Elisa Menicali, Nicole Nucci, Silvia Morelli, Renato Colella, Martina Mandarano, Angelo Sidoni et al. · 2019 · The Journal of Clinical Endocrinology & Metabolism
Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy
Yared Hailemichael, Amber N. Woods, Tihui Fu, Qiuming He, Michael C. Nielsen, Farah Hasan, Jason Roszik, Zhilan Xiao, Christina Vianden, Hiep Khong et al. · 2018 · Journal of Clinical Investigation
CXCR3-CXCL9: It’s All in the Tumor
Étienne Humblin, Alice Oliffson Kamphorst · 2019 · Immunity
Chemokine receptor engineering of T cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse model
Manja Idorn, Signe K. Skadborg, Lauge Kellermann, Hólmfridur R. Halldórsdóttir, Gitte Holmen Olofsson, Özcan Met, Per thor Straten · 2018 · OncoImmunology
Baseline Frequency of Inflammatory Cxcl9-Expressing Tumor-Associated Macrophages Predicts Response to Avelumab Treatment
Yan Qu, Ji Wen, Graham D. Thomas, Wenjing Yang, Weiwei Prior, Wenqian He, Purnima Desai Sundar, Xiao Wang, Shobha Potluri, Shahram Salek‐Ardakani · 2020 · Cell Reports
Therapeutic strategies to remodel immunologically cold tumors
Minyu Wang, Sen Wang, Jayesh Desai, Joseph A. Trapani, Paul Joseph Neeson · 2020 · Clinical & Translational Immunology
Ionizing radiation effects on the tumor microenvironment
Luigi Portella, Stefania Scala · 2019 · Seminars in Oncology
Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don’t Forget the Fuel
Melita B. Irving, Romain Vuillefroy de Silly, Kirsten B. J. Scholten, Nahzli Dilek, George Coukos · 2017 · Frontiers in Immunology
TCR-engineered T cells to treat tumors: Seeing but not touching?
Reno Debets, Emmanuel Donnadieu, Salem Chouaı̈b, George Coukos · 2016 · Seminars in Immunology
Immunomodulation of Tumor Vessels: It Takes Two to Tango
Anna Johansson, Bo He, Ruth Ganß · 2018 · Trends in Immunology
Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy
Pavlina Chuntova, Kira Downey, Bindu Hegde, Neil D. Almeida, Hideho Okada · 2019 · Frontiers in Immunology
CXCR6 by increasing retention of memory CD8 + T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer
Ravikumar Muthuswamy, AJ Robert McGray, Sebastiano Battaglia, Wenjun He, Anthony J. Miliotto, Cheryl Eppolito, Junko Matsuzaki, Takemasa Tsuji, Richard Chikara Koya, Thinle Chodon et al. · 2021 · Journal for ImmunoTherapy of Cancer
Connecting the Metabolic and Immune Responses to Cancer
Thomas R. Flint, Douglas T. Fearon, Tobias Janowitz · 2017 · Trends in Molecular Medicine
Antiangiogenic therapy combined with immune checkpoint blockade in renal cancer
Teele Kuusk, Laurence K. Albiges, Bernard J. Escudier, Nikolaos Grivas, John B.A.G. Haanen, Thomas B. Powles, Axel Bex · 2017 · Angiogenesis
Functional Role of Dendritic Cell Subsets in Cancer Progression and Clinical Implications
Annalisa Del Prete, Francesca Sozio, Ilaria Barbazza, Valentina Salvi, Laura Tiberio, Mattia Laffranchi, Angela Gismondi, Daniela Bosisio, Tiziana Schioppa, Silvano Sozzani · 2020 · International Journal of Molecular Sciences
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity
Chuan Qin, Min Zhang, Dapeng Mou, Luo‐Qi Zhou, Ming‐Hao Dong, Liang Huang, Wen Wang, Song-Bai Cai, Yun‐Fan You, Ke Shang et al. · 2024 · Science Immunology
Homing to solid cancers: a vascular checkpoint in adoptive cell therapy using CAR T-cells
Ann Ager, H. Angharad Watson, Sophie C. Wehenkel, Rebar N. Mohammed · 2016 · Biochemical Society Transactions
Baseline Frequency of Inflammatory Cxcl9-Expressing Tumor-Associated Macrophages Predicts Response to Avelumab Treatment
Yan Qu, Ji Wen, Graham D. Thomas, Wenjing Yang, Weiwei Prior, Wenqian He, Purnima Desai Sundar, Xiao Wang, Shobha Potluri, Shahram Salek‐Ardakani · 2020 · Cell Reports
The PD-1: PD-L1 pathway promotes development of brain-resident memory T cells following acute viral encephalitis
Sujata Prasad, Shuxian Hu, Wen S. Sheng, Priyanka Chauhan, Amar Ranjan Singh, James R. Lokensgard · 2017 · Journal of Neuroinflammation
Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer
Johanna Bödder, Tasmin Zahan, Rianne van Slooten, Gerty Schreibelt, I. Jolanda M. de Vries, Georgina Flórez‐Grau · 2021 · Frontiers in Immunology
CXCL10 mediates CD8+ T cells to facilitate vessel normalization and improve the efficacy of cetuximab combined with PD-1 checkpoint inhibitors in colorectal cancer
Wei Yan, Lin Qiu, Meiling Yang, Anran Xu, Manqi Ma, Qinzi Yuan, Xiaochen Ma, Wenjuan Liang, Xuenong Li, Yanxia Lu · 2023 · Cancer Letters
IL35 Hinders Endogenous Antitumor T-cell Immunity and Responsiveness to Immunotherapy in Pancreatic Cancer
Bhalchandra Mirlekar, Daniel E. Michaud, Ryan Searcy, Kevin Greene, Yuliya Pylayeva‐Gupta · 2018 · Cancer Immunology Research
Engineering Nano‐Therapeutics to Boost Adoptive Cell Therapy for Cancer Treatment
Zheng, Chunxiong, Zhang, Jiabin, Chan, Hon Fai, Hu, Hanze, Lv, Shixian, Na, Ning, Tao, Yu, Li, Mingqiang · 2021 · Small Methods
Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade
Nina Eißler, Yumeng Mao, David Brodin, Philippa Reuterswärd, Helene Andersson Svahn, John Inge Johnsen, Rolf W. Kiessling, Per Kogner · 2016 · OncoImmunology
Recent advances in understanding antitumor immunity
Rodrigo Ramella Munhoz, Michael Andrew Postow · 2016 · F1000Research
CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer
Yuanke Liang, Ze-kun- Deng, Mu-tong CHEN, Si-Qi Qiu, Yingsheng Xiao, Yuzhu Qi, Qin Xie, Zheng-hao Wang, Shicheng Jia, De Zeng et al. · 2021 · Frontiers in Oncology
Understanding the mechanisms that facilitate specificity, not redundancy, of chemokine‐mediated leukocyte recruitment
Douglas P. Dyer · 2020 · Immunology
Expansion of tumor-reactive CD8 + T cell clonotypes occurs in the spleen in response to immune checkpoint blockade
Duncan M. Morgan, Brendan L. Horton, Vidit Bhandarkar, Richard Van, Teresa Dinter, Maria Zagorulya, John Christopher Love, Stefani Spranger · 2024 · Science Immunology
The yin and yang of leukotriene B 4 mediated inflammation in cancer
Venkatakrishna Rao Jala, Sobha Rani Bodduluri, Shuchismita R. Satpathy, Zinal S. Chheda, Rajesh Kumar Sharma, Bodduluri Haribabu · 2017 · Seminars in Immunology
Targeting CXCL9/10/11–CXCR3 axis: an important component of tumor-promoting and antitumor immunity
Minjie Pan, Xiao‐Shan Wei, Xuan Xiang, Yanhong Liu, Qiong Zhou, Wei-Bing Yang · 2023 · Clinical & Translational Oncology
Angiopellosis as an Alternative Mechanism of Cell Extravasation
Tyler A. Allen, David Gracieux, Maliha Talib, Debra A. Tokarz, Michael Taylor Hensley, Jhon Cores, Adam C. Vandergriff, Junnan Tang, James B.M. de Andrade, Phuong‐Uyen Dinh et al. · 2016 · Stem Cells
A bilateral tumor model identifies transcriptional programs associated with patient response to immune checkpoint blockade
Ivy X. Chen, Kathleen Newcomer, Kristen E. Pauken, Vikram R. Juneja, Kamila Naxerova, Michelle W. Wu, Matthias Pinter, Debattama R. Sen, Meromit Singer, Arlene H. Sharpe et al. · 2020 · Proceedings of the National Academy of Sciences
Tumor inhibition or tumor promotion? The duplicity of CXCR3 in cancer
Eleonora Russo, Angela Santoni, Giovanni Bernardini · 2020 · Journal of Leukocyte Biology
Tumor Immunogenic Cell Death as a Mediator of Intratumor CD8 T-Cell Recruitment
Nicolas Roussot, François Ghiringhelli, Cédric Rébé · 2022 · Cells
The fibroinflammatory response in cancer
Zebin Xiao, Ellen Puré · 2025 · Nature reviews. Cancer
Regulators of T‐cell fate: Integration of cell migration, differentiation and function
Joanna R. Groom · 2019 · Immunological Reviews
Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells
Wenjie Gong, Jean‐Marc Hoffmann, Sophia Stock, Lei Wang, Yibin Liu, Maria‐Luisa Schubert, Brigitte Neuber, Angela Hückelhoven‐Krauss, Ulrike Gern, Anita Schmitt et al. · 2019 · Cancer Immunology Immunotherapy
Chimeric antigen receptor T cells in solid tumors: a war against the tumor microenvironment
Zijun Zhao, Xiaoyun Xiao, Phei Er Saw, Wei Wu, Hongyan Huang, Jiewen Chen, Yan Nie · 2019 · Science China Life Sciences
Impact of proton therapy on antitumor immune response
Céline Mirjolet, Anaïs Nicol, Emeric Limagne, Carole Mura, Corentin Richard, Véronique Morgand, Marc Rousseau, Romain Boidot, François Ghiringhelli, Georges Noël et al. · 2021 · Scientific Reports
Multi-Parameter Quantitative Imaging of Tumor Microenvironments Reveals Perivascular Immune Niches Associated With Anti-Tumor Immunity
Caleb R. Stoltzfus, Ramya Sivakumar, Leo Kunz, Brandy E. Olin, Elena Menietti, Dario Speziale, Roberto Adelfio, Marina Bacac, Sara Colombetti, Mario Perro et al. · 2021 · Frontiers in Immunology
Active Immunotherapy of Cancer
Thinle Chodon, Richard Chikara Koya, Kunle O. Odunsi · 2015 · Immunological Investigations
Myeloid-restricted ablation of Shp2 restrains melanoma growth by amplifying the reciprocal promotion of CXCL9 and IFN-γ production in tumor microenvironment
Peng Xiao, Yu Lian Guo, Haofei Zhang, X. Zhang, Hongqiang Cheng, Qian Cao, Yuehai Ke · 2018 · Oncogene
The onco-immunological implications of Fusobacterium nucleatum in breast cancer
Michelle van der Merwe, Gustav van Niekerk, Alfred Botha, Anna‐Mart Engelbrecht · 2021 · Immunology Letters
Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapy
Xin Liu, Yixiang Xu, Wei Xiong, Bingnan Yin, Yuqian Huang, Junjun Chu, Changsheng Xing, Qian Chen, Yang Du, Tianhao Duan et al. · 2022 · Journal for ImmunoTherapy of Cancer
Immune cellular components and signaling pathways in the tumor microenvironment
Sasitorn Yenyuwadee, Konstantinos Aliazis, Qi Wang, Anthos Christofides, Rushil Shah, Nikolaos Patsoukis, Vassiliki A. Boussiotis · 2022 · Seminars in Cancer Biology
Rational design of a JAK1-selective siRNA inhibitor for the modulation of autoimmunity in the skin
Qi Tang, Hassan H. Fakih, Mohammad Zain UI Abideen, Samuel R. Hildebrand, Khashayar Afshari, Katherine Y. Gross, Jacquelyn Sousa, Allison Maebius, Christina Bartholdy, Pia Pernille Søgaard et al. · 2023 · Nature Communications
Improving homing in T cell therapy
Debora Vignali, Marinos Kallikourdis · 2017 · Cytokine & Growth Factor Reviews
CXCR3 Signaling Is Required for Restricted Homing of Parenteral Tuberculosis Vaccine–Induced T Cells to Both the Lung Parenchyma and Airway
M. Jeyanathan, S. Afkhami, Amandeep Khera, Talveer S. Mandur, D. Damjanovic, Yushi Yao, R. Lai, S. Haddadi, A. Dvorkin-Gheva, M. Jordana et al. · 2017 · Journal of Immunology
Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist
Karin M. Knudson, Kristin C. Hicks, Yohei Ozawa, Jeffrey Schlom, Sofia R. Gameiro · 2020 · Journal for ImmunoTherapy of Cancer
Location bias contributes to functionally selective responses of biased CXCR3 agonists
Dylan Scott Eiger, Noelia M. Boldizsar, Christopher Cole Honeycutt, Julia Gardner, Stephen J. Kirchner, Chloe Hicks, Issac Choi, Uyen Pham, Kevin Zheng, Anmol Warman et al. · 2022 · Nature Communications
Immunology‐Guided Biomaterial Design for Mucosal Cancer Vaccines
Shiran Ferber, Rodrigo J. Gonzalez, Alexander M. Cryer, Ulrich H. von Andrian, Natalie Artzi · 2019 · Advanced Materials
CXCL10 Is an Agonist of the CC Family Chemokine Scavenger Receptor ACKR2/D6
Andy Chevigné, Bassam Janji, Max Meyrath, Nathan Reynders, Giulia D’Uonnolo, Tomasz Uchański, Malina Xiao, Guy Berchem, Markus W. Ollert, Yong‐Jun Kwon et al. · 2021 · Cancers
Stress keratin 17 enhances papillomavirus infection-induced disease by downregulating T cell recruitment
Wei Wang, Aayushi Uberoi, Megan E. Spurgeon, Ellery Gronski, Vladimır Majerčiak, Alexei V. Lobanov, Mitchell Hayes, Amanda S. W. Loke, Zhi‐Ming Zheng, Paul F. Lambert · 2020 · PLoS Pathogens
Human pDCs Are Superior to cDC2s in Attracting Cytolytic Lymphocytes in Melanoma Patients Receiving DC Vaccination
Jasper J. P. van Beek, Georgina Flórez‐Grau, Mark A.J. Gorris, Till S. M. Mathan, Gerty Schreibelt, Kalijn F. Bol, Johannes C. Textor, I. Jolanda M. de Vries · 2020 · Cell Reports
EZH2 as a Regulator of CD8+ T Cell Fate and Function
Christopher J. Stairiker, Graham D. Thomas, Shahram Salek‐Ardakani · 2020 · Frontiers in Immunology
Imaging CAR T-cell kinetics in solid tumors: Translational implications
Matthew S. Skovgard, Hocine R. Hocine, Jasmeen K. Saini, Maxim A. Moroz, Rebecca Y. Bellis, Srijita Banerjee, Aurore Morello, Vladimir Ponomarev, Jonathan Villena‐Vargas, Prasad S. Adusumilli · 2021 · Molecular Therapy — Oncolytics
Innate Immune Cells and Their Contribution to T-Cell-Based Immunotherapy
Pierpaolo Ginefra, Girieca Lorusso, Nicola Vannini · 2020 · International Journal of Molecular Sciences
Interactions between Cancer-Associated Fibroblasts and T Cells in the Pancreatic Tumor Microenvironment and the Role of Chemokines
Laia Gorchs, Helen Kaipe · 2021 · Cancers
Temperature and adaptive immunity
Michelle M. Appenheimer, Sharon S. Evans · 2018 · Handbook of clinical neurology
Interleukin-8 in Melanoma Pathogenesis, Prognosis and Therapy—An Integrated View into Other Neoplasms and Chemokine Networks
Anca Filimon, Iulia A. Preda, Adina F. Boloca, Gabriela Negroiu · 2021 · Cells
Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma
Shuo Liu, Zhen Qin, Yaqing Mao, Wenbo Zhang, Yujia Wang, Lingfei Jia, Xin Peng · 2022 · OncoImmunology
Programming of Distinct Chemokine-Dependent and -Independent Search Strategies for Th1 and Th2 Cells Optimizes Function at Inflamed Sites
Alison E. Gaylo, Hen Prizant, Milan Popović, Ninoshka R.J. Fernandes, Christopher Anderson, Kevin K. Chiou, Hannah Bell, Dillon C. Schrock, Justin S. Schumacher, Tara Capece et al. · 2019 · Immunity
Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic Targets
Robin Reschke, Alexander Heinrich Enk, Jessica C. Hassel · 2024 · International Journal of Molecular Sciences
The intratumoral CXCR3 chemokine system is predictive of chemotherapy response in human bladder cancer
Tino Vollmer, Stephan Schlickeiser, Leila Amini, Sarah Schulenberg, Désirée J. Wendering, Viqar Showkat Banday, Anke Jurisch, Rebecca Noster, Désirée Kunkel, Nicola R. Brindle et al. · 2021 · Science Translational Medicine
Cooperative immune-mediated mechanisms of the HDAC inhibitor entinostat, an IL15 superagonist, and a cancer vaccine effectively synergize as a novel cancer therapy
Hicks, Kristin C., Knudson, Karin M., Lee, Karin L., Hamilton, Duane H., Hodge, James W., Figg, William D., Ordentlich, Peter, Jones, Frank R., Rabizadeh, Shahrooz, Soon-Shiong, Patrick et al. · 2020 · Clinical Cancer Research
RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers
Li Xia, Enming Tian, Mingcheng Yu, Chenglong Liu, Lian Shen, Yafei Huang, Zhongen Wu, Jinlong Tian, Ker Yu, Yonghui Wang et al. · 2022 · Journal of Experimental & Clinical Cancer Research
Differential Expression of Homing Receptor Ligands on Tumor-Associated Vasculature that Control CD8 Effector T-cell Entry
Amber N. Woods, Ashley Lauren Wilson, Nithya Srivinisan, Jianhao Zeng, Arun B. Dutta, J. David Peske, Eric F. Tewalt, Randal K. Gregg, Andrew R. Ferguson, Víctor H. Engelhard · 2017 · Cancer Immunology Research
Interplay between dendritic cells and cancer cells
Jan Martínek, Te-Chia Wu, Diana Cadena, Jacques Banchereau, Karolina Palucka · 2019 · International review of cytology
M1-like TAMs are required for the efficacy of PD-L1/PD-1 blockades in gastric cancer
Rui Zhao, Qianyi Wan, Yong Wang, Yutao Wu, Shuomeng Xiao, Qiqi Li, Xiaoding Shen, Wen Zhuang, Yong Zhou, Lin Xia et al. · 2020 · OncoImmunology
GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models
Robert J. Torphy, Yi Sun, Ronggui Lin, Alayna K. Caffrey-Carr, Yuki Fujiwara, Felix Ho, Emily N. Miller, Martin D. McCarter, Traci Renae Lyons, Richard David Schulick et al. · 2022 · Nature Communications
Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING
Liqun Wang, Ren Luo, Kateryna Onyshchenko, Xi Rao, Meidan Wang, Beatrice Menz, Simone Gaedicke, Anca‐Ligia Grosu, Elke Firat, Gabriele Niedermann · 2023 · Journal for ImmunoTherapy of Cancer
Obstacles to T cell migration in the tumor microenvironment
Alba Nicolás‐Boluda, Emmanuel Donnadieu · 2018 · Comparative Immunology Microbiology and Infectious Diseases
Interleukin-1β induces CXCR3-mediated chemotaxis to promote umbilical cord mesenchymal stem cell transendothelial migration
Yu-Chien Guo, Yun-Hsuan Chiu, Chie‐Pein Chen, Hwai-Shi Wang · 2018 · Stem Cell Research & Therapy
New directions in chimeric antigen receptor T cell [CAR‐T] therapy and related flow cytometry
Elena Maryamchik, Kathleen Gallagher, Frederic I. Preffer, Stephan Kadauke, Marcela Valderrama Maus · 2020 · Cytometry Part B Clinical Cytometry
Immune-Stimulatory Effects of Rapamycin Are Mediated by Stimulation of Antitumor γδ T Cells
Vinh A Dao, Yang Liu, Srilakshmi Pandeswara, Robert Scott Svatek, Jonathan Gelfond, Aijie Liu, Vincent J. Hurez, Tyler Jay Curiel · 2016 · Cancer Research
Integration of Nano drug-delivery System With Cancer Immunotherapy
Takashi Nakamura, Hideyoshi Harashima · 2017 · Therapeutic Delivery
Improved migration of tumor ascites lymphocytes to ovarian cancer microenvironment by CXCR2 transduction
Manja Idorn, Maria Olsen, Hólmfridur R. Halldórsdóttir, Signe K. Skadborg, Magnus Pedersen, Claus Kim Høgdall, Estrid Vilma Solyom Høgdall, Özcan Met, Per thor Straten · 2017 · OncoImmunology
Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones?
N Karin · 2021 · Cancers
Proximity-dependent labeling identifies dendritic cells that drive the tumor-specific CD4 + T cell response
Aleksey Chudnovskiy, Tiago B. R. Castro, Sandra Nakandakari-Higa, Ang Cui, Chia‐Hao Lin, Moshe Sade-Feldman, Brooke K. Phillips, Juhee Pae, Luka Mesin, Juliana Bortolatto et al. · 2024 · Science Immunology
Cross-linking of T cell to B cell lymphoma by the T cell bispecific antibody CD20-TCB induces IFNγ/CXCL10-dependent peripheral T cell recruitment in humanized murine model
Floriana Cremasco, Elena Menietti, Dario Speziale, Johannes Sam, Stefano Sammicheli, Marine Richard, Ahmet Varol, Christian Klein, Pablo Umaña, Marina Bacac et al. · 2021 · PLoS ONE
Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing
Eric Alves, Shahama Taifour, Riccardo Dolcetti, Jonathan Chee, Anna K. Nowak, Silvana Gaudieri, Pilar Blancafort · 2021 · Molecular Therapy — Methods & Clinical Development
Spatial determinants of CD8+ T cell differentiation in cancer
Katherine Tooley, Giulia Escobar, Ana Carrizosa Anderson · 2022 · Trends in cancer
CXCL10 and Nrf2-upregulated mesenchymal stem cells reinvigorate T lymphocytes for combating glioblastoma
Jiaji Mao, Jianing Li, Junwei Chen, Qin Wen, Minghui Cao, Fang Zhang, Baoxun Li, Qinyuan Zhang, Zhe Wang, Jingzhong Zhang et al. · 2023 · Journal for ImmunoTherapy of Cancer